Formulation Development and Evaluation of Extended Release Dosage form of Cilostazol for Treathment of Intermittent Chau

Guardat en:

Dades bibliogràfiques
Autor principal:	Desai Chirag T.
Format:	Thesis Llibre
Idioma:	anglès
Publicat:	Mumbai NMIMS-SPPSPTM 2015
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars

FORMULATION DEVELOPMENT AND EVALUATION OF EXTENDED RELESES DOSAGE FORM OF CLIOSTAZOL FOR TREATMENT OF INTERMITTENT CLAUD
per: DESAI CHIRAG

FORMULATION AND EVALUATION OF EXTENDED RELEASE SOLID ORAL DOSAGE FORM OF DRUG X
per: DESAI RAVI

FORMULATION DEVELOPMENT AND EVALUATION OF AN EXTENDED RELEASE DOSAGE FOR MOF AN ANTIHYPERTENSIVE AGENTS
per: PATEL HITESH

Development and Evaluation of Extended Release Dosage Forms of Anti-Diabetic Drugs
per: Srivastav Monika
Publicat: (2012)

PREPARATION AND EVALUATION OF LORNOXICAM EXTENDED RELEASE FORMULATION
per: NAVANDAR SHRADDHA

FORMULATION DEVELOPMENT AND EVALUATION OF EXTENDED RELEASE ANTI-ANGINAL TABLETS
per: CHOKSHI DWEEP

FORMULATION DEVELOPMENT AND EVALUATION OF BUPROPION HYDROCHLORIDE EXTENDED RELEASE TABLETS
per: PATADE PRAGATI

FORMULATION DEVELOPMENT AND EVALUATION OF EXTENDED RELEASE CAPSULE OF TOLTERODINE TARTRATE
per: PATEL JAIMINKUMAR

DEVELOPMENT & FORMULATION OF?.DOSAGE FORMS
per: HARDEE GREGORY E (ED.)

FORMULATION AND DEVELOPMENT OF ANTICONVULSANT EXTENDED RELEASE TABLETS
per: PATEL KARISHMA

FORMULATION, DEVELOPMENT AND IN-VITRO EVALUATION OF EXTENDED RELEASE CAPSULES BY WURSTER TECHNOLOGY
per: DUDANI KEYUR

FORMULATION DEVELOPMENT AND EVALUATION OF AN EXTENDED RELEASE GASTRORETENTIVE TABLETS FOR AN ANTIHYPERTENSIVE DRUG
per: JAIN ABHISHEK

FORMULATION DEVELOPMENT AND EVALUATION OF EXTENDED RELEASE TABLETS OF AN ANTI-HYPERTENSIVE DRUG
per: KOTHARI HARSH

FORMULATION AND EVALUATION OF ISOSORBIDE-5- MONONITRATE EXTENDED RELEASE TABLET
per: PATIL GAURAV

DEVELOPMENT AND EVALUATION OF ONCE A DAILY ORAL DOSAGE FORM OF LAMOTRIGINE
per: SHAH CHIRAG

DEVELOPMENT AND FORMULATION OF VETERNIARY DOSAGE FORMS
per: HARDEE GREGORY E [E], BAGGOT J DESMOND [E]
Publicat: (1998)

FORMULATION AND EVALUATION OF SODIUM VALPROATE AND VALPROIC ACID EXTENDED RELEASE TABLET
per: DAFTARY ADITI

FORMULATION AND EVALUATION OF EXTENDED RELEASE MATRIX TABLET OF HIGHLY SOLUBLE DRUG
per: DAFTARDAR SALONI

TO ENHANCE THE SOLUBILITY AND DEVELOP THE LIPOSOMES OF CILOSTAZOL
per: JAGTAP HRISHIKESH

PREPARATION AND EVALUATION OF FELODIPINE EXTENDED RELEASE CAPSULES
per: VIJAYAN VIVEK

FORMULATION AND EVALUATION OF NEW OPHTHALMIC DOSAGE FORM OF GATIFLOXACIN
per: PALKAR MAYURESH

CONTROLLED RELEASE DOSAGE FORM DESIGN
per: CHERNG -JU KIM
Publicat: (2000)

FORMULATION DEVELOPMENT AND EVALUATION OF DELAYED RELEASE TABLET FORMULATION
per: SHAH SNEHAL

FORMULATION DEVELOPMENT AND EVALUATION OF FIXED DOSE COMBINATION FOR HYPERTENSION
per: DESAI CHIRAG

FORMULATION DEVELOPMENT AND EVALUATION OF EXTENDED RELEASE TABLETS OF HIGHLY WATER SOLUBLE DRUG X
per: SHAHI JAYA

FORMULATION PROCESS DEVELOPMENT AND EVALUATION OF FILM COATED ANTIEPILEPTIC EXTENDED RELEASE MATRIX TABLET
per: SHAH BHAUMIK

FORMULATION DEVELOPMENT AND EVALUATION OF EXTENDED RELEASE MULTIPARTICULATE DRUG DELIVERY SYSTEMS CONTAINING AN ANTIADRE
per: RUSTAGI DOLLY

Science of intermittent fasting
per: Vanderschelden, M
Publicat: (2019)

FORMULATION AND EVALUATION OF FELODIPINE EXTENDED RELEASE TABLETS BY HOT MELT GRANULATION METHOD
per: PRIYADARSHI JIGAR

FORMULATION DEVELOPMENT AND EVALUATION OF EXTENDED RELEASE TABLETS CONTAINING ANTI-PSYCHOTIC AGENT DRUG 'X'
per: DUBEY POOJA

FORMULATION DEVELOPMENT AND EVALUATION OF A BILAYER EXTENDED RELEASE TABLET CONTAINING ANALGESIC AND ANTIPYRETIC AGENTS
per: PAWAR VIKAS

FORMULATION DEVELOPMENT AND EVALUATION OF XYZ/ABC EXTENDED RELEASE BILAYER TABLETS CONTAINING ANTIHYPERTENSIVE AGENTS
per: HELGAR KISHORE

FORMULATION AND DEVELOPMENT OF EXTENDED RELEASE TABLETS OF A B-BLOCKING AGENT
per: RAKSHIT PUSHPITA

FORMULATION AND DEVELOPMENT OF ANTI-PARKINSON DRUG-X EXTENDED RELEASE TABLETS
per: PATEL KRUTI

FORMULATION DEVELOPMENT AND EVALUATION OF ORAL SOLID DOSAGE FORM CONTAINING AN ANTISYCHOTIC AGENT
per: MOHITE ASHISH

DEVELOPMENT AND EVALUATION OF ABT 01 EXTENDED RELEASE TABLET AS PER USP
per: DAVE SHIVAM

FORMULATION AND DEVELOPMENT OF LIQUID DOSAGE FORM LEVOFLOXACIN HEMIHYDRATE
per: PIYUSH PATEL

FORMULATION AND EVALUATION OF PROLIPOSOMES OF BENDAMUSTINE HYDROCHLORIDE INTO A POWDER DOSAGE FORM
per: YADAV INDU

FORMULATION DEVELOPMENT AND EVALUATION OF IMMEDIATE RELEASE TABLETS OF AN ANTIDIABETIC DRUG A
per: DESAI NEEL

FORMULATION AND EVALUATION OF BILAYERED TABLET OF TRIMETAZIDINE DIHYDROCHLORIDE 35mg EXTENDED RELEASE AND METOPROLOL TAR
per: PATIL NISHA